Mahdi Rezai

Mahdi Rezai

Auto-generated profile, based on publicly available information

Mahdi Rezai

Emergency Medicine Management Research Center, Health Management Research Institute, School of Medicine, Iran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2017 in Journal of Ultrasound
Verified
Journal Article
Closed access
PDF file
DFDavood Farsi
Davood Farsi
SHSkokoufeh Hajsadeghi
Skokoufeh Hajsadeghi
MHMohammad Javad Hajighanbari
Mohammad Javad Hajighanbari
MMMani Mofidi
Mani Mofidi
PHPeyman Hafezimoghadam
Peyman Hafezimoghadam
SASaeed Abbasi
Saeed Abbasi

26 December 2017 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
BMBabak Mahshidfar
Babak Mahshidfar
MMMani Mofidi
Mani Mofidi
MFMaryam Fattahi
Maryam Fattahi
DFDavood Farsi
Davood Farsi
PMPeyman Hafezi Moghadam
Peyman Hafezi Moghadam
MRMahdi Rezai
Mahdi Rezai
Background: Ketamine, as an opium alternative, has been proposed for pain relief in the emergency department (ED). Objectives: This study was carried out to compare low dose ketamine (LDK) with morphine for pain relief in trauma patients. Methods: In this randomized double-blinded clinical trial, 300 trauma patients from the ED of 2 teaching hospitals in Tehran, Iran were enrolled and randomly divided into 2 equal groups. The 1st group received 0.2 mg/kg of ketamine while the 2nd group received 0.1 mg/kg of intravenous morphine. The pain intensity and complications were measured and compared every 15 minutes to 1 hour. Results: Fifteen minutes after drug injection in both groups, a significant reduction was found in average pain intensity compared to the initial pain (P = 0.01). At 15 minutes, no significant difference was found in both groups in regards to average pain intensity (P = 0.23). The average pain intensity at 30, 45, and 60 minutes in the group receiving morphine was lower than the ketamine group (P = 0.01, P < 0.001, P < 0.001 respectively). Two complications (drop in O2 saturation below 90% and flushing) were significantly greater in the morphine group. Conclusions: The results of this study suggest that LDK, at a dose of 0.2 mg/kg, in the earlier minutes leads to significant reduction of pain when compared to that of intravenous morphine. It also created fewer complications than morphine. Keywords: Morphine; Ketamine; Pain; Emergency Department

12 May 2021 in Journal of Cutaneous Pathology
Verified
Journal Article
Open access
PDF file
ASAfsaneh Sadeghzadeh‐Bazargan
Afsaneh Sadeghzadeh‐Bazargan
MRMahdi Rezai
Mahdi Rezai
NNNiloufar Najar Nobari
Niloufar Najar Nobari
SMSamaneh Mozafarpoor
Samaneh Mozafarpoor
AGAzadeh Goodarzi
Azadeh Goodarzi
As a respiratory viral infection caused by a novel coronavirus, COVID‐19 became rapidly pandemic within a few months. Despite the wide range of manifestations and organ involvement in COVID‐19 patients, the exact pathogenesis of severe and fatal types of COVID‐19 and causes involved with the individual base of the disease is not yet understood. Several studies have reported clinical, laboratory, and histopathological data in favor of vascular injury in multiple organs of critically ill patients with COVID‐19 as a result of hyperactive immune response, inflammation, and cytokine storm. Also, both clinical and histopathological evidence points to such vascular involvements in the skin. Given the ease of clinical examinations and skin biopsy and the lower risks of transmission of COVID‐19 to healthcare workers, the present review article was conducted to investigate the vascular skin manifestations of COVID‐19 patients clinically and/or histopathologically as helpful clues for better understanding the pathogenesis and predicting the prognosis of the disease, especially in severe cases.

14 September 2016 in Integrative Cancer Therapies
Verified
Journal Article
Open access
CHCarolin C. Hack
Carolin C. Hack
Peter FaschingPeter Fasching
Peter Fasching
TFTanja Fehm
Tanja Fehm
JWJohann de Waal
Johann de Waal
MRMahdi Rezai
Mahdi Rezai
DPDaniela Paepke
Daniela Paepke
Background. Breast cancer patients often use complementary and alternative medicine, but few prospectively collected data on the topic are available specifically for postmenopausal breast cancer patients. A large prospective study was therefore conducted within a noninterventional study in order to identify the characteristics of patients interested in integrative medicine. Methods. The EvAluate-TM study is a prospective, multicenter noninterventional study in which treatment with the aromatase inhibitor letrozole was evaluated in postmenopausal women with hormone receptor–positive primary breast cancer. Between 2008 and 2009, 5045 postmenopausal patients were enrolled at 339 certified breast centers in Germany. As part of the data collection process, patients were asked at the baseline about their interest in and information needs relating to integrative medicine. Results. Of the 5045 patients recruited, 3411 responded to the questionnaire on integrative medicine and took part in the analysis, 1583 patients expressed an interest in integrative medicine, and 1828 patients declared no interest. Relevant predictors of interest in integrative medicine were age, body mass index, tumor size, previous chemotherapy, and use of concomitant medications for other medical conditions. Interest in integrative medicine declined highly significantly (P < .001) with age (65 years, 38.0%). Patients in favor of integrative medicine were significantly less satisfied with the information received about individual treatments and antihormonal therapy. Patients with interest in integrative medicine were more often interested in rehabilitation and fitness, nutritional counseling, and additional support from self-help organizations. These women were mostly interested in receiving information about their disease and integrative medicine from a physician, rather than from other sources. Conclusions. This study shows that a considerable proportion of postmenopausal breast cancer patients are interested in integrative medicine. Information about integrative medicine should therefore be provided as part of patient care for this group. It was found that receiving concomitant medication for other medical conditions is one of the main predictors for women not being interested in integrative medicine. This group of patients may need special attention and individualized information about integrative medicine. Additionally, most patients were interested in obtaining the relevant information from their doctor.

1 April 2008 in Gynäkologisch-geburtshilfliche Rundschau
Verified
Journal Article
Closed access
SKStefan Krämer
Stefan Krämer
MDMaren Darsow
Maren Darsow
SKSherko Kümmel
Sherko Kümmel
RKRainer Kimmig
Rainer Kimmig
MRMahdi Rezai
Mahdi Rezai
Breast-conserving surgery combined with radiotherapy has become the treatment of choice for the majority of women presenting with primary breast cancer over the last 20 years. The extent of local excision remains a controversial issue in breast-conserving surgery. The wider the margins of clearance, the lower the risk of incomplete excision and thus of local recurrences, but the greater the amount of tissue removed, the higher the risk of visible deformity leading to an unacceptable cosmetic result. This clash of interests is most evident when attempting breast-conserving surgery in patients with smaller breast-tumor ratios. The widespread popularity of breast-conserving surgery has focused attention on new oncoplastic techniques that can avoid unacceptable cosmetic results. Partial mastectomy defects can be reconstructed by volume displacement, recruiting and transposing local glandular or dermoglandular flaps into the resection site, or by volume replacement, importing volume from elsewhere to replace the amount of tissue resected.

1 March 2000 in The Breast Journal
Verified
Journal Article
Open access
PDF file
KSKerstin Struse
Kerstin Struse
WAWerner Audretsch
Werner Audretsch
MRMahdi Rezai
Mahdi Rezai
GPGuido Pott
Guido Pott
HBHans Bojar
Hans Bojar
Occasional reports have suggested an unfavorable effect of high estrogen receptor (ER) concentrations in primary breast cancer. In a population‐based study we identified a subgroup explicit...